Why PEPFAR's top scientist stepped down

Mike Reid, the former chief science officer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), resigned amid growing concerns over shifts in America’s global health strategy. Reid cited discomfort with the Trump administration’s approach to foreign aid, which increasingly tied health funding to broader commercial and geopolitical interests. He warned that linking lifesaving treatments to negotiations over resources such as mineral rights risks undermining the humanitarian mission of programs like PEPFAR. Reid expressed unease about reconciling U.S. foreign policy priorities with the goals of global health initiatives. While acknowledging the role of soft power in health diplomacy, he criticized the conditionality now attached to aid, which could jeopardize access to essential HIV prevention and treatment services. His departure highlights tensions within the global health community regarding the balance between moral imperatives and strategic national interests in foreign assistance. Recent PEPFAR data from 2024 revealed significant declines in HIV testing and prevention services, although treatment retention remains relatively stable in many countries. Reid emphasized that these reductions are particularly concerning because HIV disproportionately affects marginalized populations, who may face greater barriers to care amid funding and policy shifts. The uneven impact on vulnerable groups underscores the potential human cost of politicizing global health programs. This development raises important questions about the future of U.S. involvement in global health, especially in the fight against HIV/AIDS. PEPFAR has been a cornerstone of international HIV response for over two decades, and changes in its funding and operational model could affect progress toward epidemic control. Reid’s resignation serves as a cautionary signal about the risks of intertwining health aid with broader geopolitical agendas.